FSC BRITFOS-50
10 South Colonnade
Canary Wharf
London E14 4PU
United Kingdom
Certificate number: 512022189631/25
Order date: 23/09/2025
CFS Expiry date: 22/09/2026
Medicines and Healthcare products
Regulatory Agency
On behalf of the Secretary of State for Health and Social Care
CERTIFICATE OF FREE SALE FOR EXPORTATION OF ANIMAL PRODUCTS
It is hereby certified that the product named below, which is manufactured and authorized, have been affixed with the relevant conformity marking(s) e.g. CE under EU MDD 93.42.EEC,CE under EU IVDD 98/79/EC, UKCA under UK MDR (2002/618) Part II and may be freely sold in Great Britain (England, Scotland, Wales).
Where appropriate, certificates of free sales are issued as a service to UK exporters. A certificate of Free Sale should not be taken as an official endorsement of any product that is referred to on the certificate. In issuing Certificates of Free Sale, the MHRA does not assess or verify that the product complies with these requirements and restrictions.
Description | Content | Date Of Initial Authorization | ||
BRITFOS50 Oral WSP Reg. No. Vm 19968/40301 | Active substance: (Each 1 Gram) Fosfomycin Calcium (as monohydrate) 500 mg Excipients: For the full list of excipients, see summary of product characteristics section 6.1. | 29 November 2019 | ||
|
|
| ||
Shelf Life: 36 months Marketed Packaging: 1kg, 500gr, 100gr
Authorization Holder: |
|
| ||
Brit Pharma Ltd 71-75 Shelton Street, Covent Garden, London, United Kingdom. WC2H 9JQ Co. No. 14455953 |
|
| ||
Carla Glanville
MPIG-Business Unit
Signed on Behalf of the
Department for Environment
Food and Rural Affairs